| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Cell Biology and Neuroanatomy, University of Minnesota Medical School, Minneapolis, Minnesota 55455
Address all correspondence and requests for reprints to: Robert L. Sorenson, Ph.D., Department of Cell Biology and Neuroanatomy, University of Minnesota Medical School, 4–157 Jackson Hall, 321 Church Street SE, Minneapolis, Minnesota 55455. E-mail: soren{at}lenti.med.umn.edu
The major changes in pancreatic islet function during pregnancy and after exposure to lactogens are an increase in ß-cell proliferation and enhanced insulin secretion. In this study we examined INS-1 cells as a potential model for further inquiry into PRL signaling in ß-cells. Proliferation of ß-cells, insulin secretion, and quantitative immunocytochemical analysis of STAT5 translocation were studied.
PRL treatment of INS-1 cells resulted in a 2- to 4-fold increase in cell proliferation compared to that in the control group. In contrast, there was no effect of PRL treatment on HIT cell proliferation and only a very small effect on RIN cell proliferation. A significant effect on INS-1 cell proliferation was observed at 10 ng/ml and reached a maximum at 200 ng/ml.
PRL treatment resulted in enhanced insulin secretion from INS-1 cells. There was a time-dependent increase in insulin secretion, which when corrected for cell number was 1.5-fold greater in the PRL-treated cells. The effects of PRL on cell division and insulin secretion were glucose dependent.
The presence of the JAK family of tyrosine kinases and the transcription factor STAT5 in INS-1 cells was examined by immunocytochemical techniques. Although all members of the JAK family of kinases were detected, the staining intensity of JAK-2 was noticeably more intense. Initial studies of STAT5 translocation were performed using PRL-dependent Nb2 lymphoma cells, in which PRL treatment resulted in a nearly complete translocation of cytoplasmic STAT5 to the nucleus. Under control conditions there was a near-equal fluorescence intensity of STAT5 staining in the nucleus and cytoplasm of INS-1 cells. PRL treatment resulted in a time-dependent increase in STAT5 staining in the nucleus, with a corresponding decrease in the cytoplasm. The STAT5 staining intensity in the nucleus remained elevated for the duration of PRL treatment. This effect was reversible upon removal of PRL from the medium. Besides PRL, both GH and FBS induced a similar translocation of STAT5 to the nucleus. Although present in RIN cells, no detectable changes in STAT5 were observed in RIN cells after exposure to PRL, GH, or FBS.
INS-1 cells should provide a good model for further inquiry into the intracellular signaling pathways used by PRL and how these events alter islet function.
This article has been cited by other articles:
 |
|
 |
|
  M. M. Sachdeva and D. A. Stoffers Minireview: Meeting the Demand for Insulin: Molecular Mechanisms of Adaptive Postnatal ss-Cell Mass Expansion Mol. Endocrinol., June 1, 2009; 23(6): 747 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Sorenson and T. C. Brelje Prolactin Receptors Are Critical to the Adaptation of Islets to Pregnancy Endocrinology, April 1, 2009; 150(4): 1566 - 1569. [Full Text] [PDF]
|
|
|
|
 |
|
 A. J Weinhaus, L. E Stout, N. V Bhagroo, T C. Brelje, and R. L Sorenson Regulation of glucokinase in pancreatic islets by prolactin: a mechanism for increasing glucose-stimulated insulin secretion during pregnancy J. Endocrinol., June 1, 2007; 193(3): 367 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Cozar-Castellano, M. Haught, and A. F. Stewart The Cell Cycle Inhibitory Protein p21cip Is Not Essential for Maintaining {beta}-Cell Cycle Arrest or {beta}-Cell Function In Vivo Diabetes, December 1, 2006; 55(12): 3271 - 3278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Cozar-Castellano, N. Fiaschi-Taesch, T. A. Bigatel, K. K. Takane, A. Garcia-Ocana, R. Vasavada, and A. F. Stewart Molecular Control of Cell Cycle Progression in the Pancreatic {beta}-Cell Endocr. Rev., June 1, 2006; 27(4): 356 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Johansson, G. Mattsson, A. Andersson, L. Jansson, and P.-O. Carlsson Islet Endothelial Cells and Pancreatic {beta}-Cell Proliferation: Studies in Vitro and during Pregnancy in Adult Rats Endocrinology, May 1, 2006; 147(5): 2315 - 2324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Cozar-Castellano, M. Weinstock, M. Haught, S. Velazquez-Garcia, D. Sipula, and A. F. Stewart Evaluation of {beta}-Cell Replication in Mice Transgenic for Hepatocyte Growth Factor and Placental Lactogen: Comprehensive Characterization of the G1/S Regulatory Proteins Reveals Unique Involvement of p21cip Diabetes, January 1, 2006; 55(1): 70 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Jensen, E. D Galsgaard, A. E Karlsen, Y. C Lee, and J. H Nielsen STAT5 activation by human GH protects insulin-producing cells against interleukin-1{beta}, interferon-{gamma} and tumour necrosis factor-{alpha}-induced apoptosis independent of nitric oxide production J. Endocrinol., October 1, 2005; 187(1): 25 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Fujinaka, D. Sipula, A. Garcia-Ocana, and R. C. Vasavada Characterization of Mice Doubly Transgenic for Parathyroid Hormone-Related Protein and Murine Placental Lactogen: A Novel Role for Placental Lactogen in Pancreatic {beta}-Cell Survival Diabetes, December 1, 2004; 53(12): 3120 - 3130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Brelje, L. E. Stout, N. V. Bhagroo, and R. L. Sorenson Distinctive Roles for Prolactin and Growth Hormone in the Activation of Signal Transducer and Activator of Transcription 5 in Pancreatic Islets of Langerhans Endocrinology, September 1, 2004; 145(9): 4162 - 4175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Graichen, J. Sandstedt, E. L. K. Goh, O. G. P. Isaksson, J. Tornell, and P. E. Lobie The Growth Hormone-binding Protein Is a Location-dependent Cytokine Receptor Transcriptional Enhancer J. Biol. Chem., February 14, 2003; 278(8): 6346 - 6354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Lingohr, L. M. Dickson, J. F. McCuaig, S. R. Hugl, D. R. Twardzik, and C. J. Rhodes Activation of IRS-2--Mediated Signal Transduction by IGF-1, but not TGF-{alpha} or EGF, Augments Pancreatic {beta}-Cell Proliferation Diabetes, April 1, 2002; 51(4): 966 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. C. Brelje, A. M. Svensson, L. E. Stout, N. V. Bhagroo, and R. L. Sorenson An Immunohistochemical Approach to Monitor the Prolactin-induced Activation of the JAK2/STAT5 Pathway in Pancreatic Islets of Langerhans J. Histochem. Cytochem., March 1, 2002; 50(3): 365 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Holness and M. C. Sugden Dexamethasone during Late Gestation Exacerbates Peripheral Insulin Resistance and Selectively Targets Glucose-Sensitive Functions in {beta} Cell and Liver Endocrinology, September 1, 2001; 142(9): 3742 - 3748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Fleenor and M. Freemark Prolactin Induction of Insulin Gene Transcription: Roles of Glucose and Signal Transducer and Activator of Transcription 5 Endocrinology, July 1, 2001; 142(7): 2805 - 2810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. N. Friedrichsen, E. D. Galsgaard, J. H. Nielsen, and A. Møldrup Growth Hormone- and Prolactin-Induced Proliferation of Insulinoma Cells, INS-1, Depends on Activation of STAT5 (Signal Transducer and Activator of Transcription 5) Mol. Endocrinol., January 1, 2001; 15(1): 136 - 148. [Abstract] [Full Text]
|
|
|
|
|
|
R. C. Vasavada, A. Garcia-Ocana, W. S. Zawalich, R. L. Sorenson, P. Dann, M. Syed, L. Ogren, F. Talamantes, and A. F. Stewart Targeted Expression of Placental Lactogen in the Beta Cells of Transgenic Mice Results in Beta Cell Proliferation, Islet Mass Augmentation, and Hypoglycemia J. Biol. Chem., May 12, 2000; 275(20): 15399 - 15406. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Heitmeier, A. L. Scarim, and J. A. Corbett Prolonged STAT1 Activation Is Associated with Interferon-gamma Priming for Interleukin-1-induced Inducible Nitric-oxide Synthase Expression by Islets of Langerhans J. Biol. Chem., October 8, 1999; 274(41): 29266 - 29273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. D. Galsgaard, J. H. Nielsen, and A. Moldrup Regulation of Prolactin Receptor (PRLR) Gene Expression in Insulin-producing Cells. PROLACTIN AND GROWTH HORMONE ACTIVATE ONE OF THE RAT PRLR GENE PROMOTERS VIA STAT5a AND STAT5b J. Biol. Chem., June 25, 1999; 274(26): 18686 - 18692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Herrington, L. Rui, G. Luo, L.-y. Yu-Lee, and C. Carter-Su A Functional DNA Binding Domain Is Required for Growth Hormone-induced Nuclear Accumulation of Stat5B J. Biol. Chem., February 19, 1999; 274(8): 5138 - 5145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-A. Huotari, J. Palgi, and T. Otonkoski Growth Factor-Mediated Proliferation and Differentiation of Insulin-Producing INS-1 and RINm5F Cells: Identification of Betacellulin as a Novel {beta}-Cell Mitogen Endocrinology, April 1, 1998; 139(4): 1494 - 1499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sjoholm, Q. Zhang, N. Welsh, A. Hansson, O. Larsson, M. Tally, and P.-O. Berggren Rapid Ca2+ Influx and Diacylglycerol Synthesis in Growth Hormone-mediated Islet beta -Cell Mitogenesis J. Biol. Chem., July 7, 2000; 275(28): 21033 - 21040. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
